Departed
Ben Hansel
director
TGNT ·
Totaligent, Inc.
Effective April 18, 2025, Ben Hansel resigned as a director of Totaligent, Inc. (the “Company”).
Ready 8-Ks
9
Latest filing
April 15, 2026, 7:59 PM ET
Top materiality
0.75
Event mix
m_and_a ×4 · other_material ×3 · other ×1
Sentiment
0 pos · 0 neg · 9 neu
Executive change
recent →
Recent 8-K filings for TGNT
Highest-materiality recent filing
Totaligent acquires Aetherium Medical ($10M rev); Klarich President, board member
- Totaligent forms subsidiary Aetherium Medical LLC; Klarich contributes trade secrets, know-how, and business network.
- Ivan Klarich appointed President immediately, will join 3-member Board after closing.
-
Totaligent acquires Aetherium Medical ($10M rev); Klarich President, board member
Totaligent forms subsidiary Aetherium Medical LLC; Klarich contributes trade secrets, know-how, and business network.
-
Totaligent extends GloMed joint venture LOI deadline to April 22, 2026
Extension Amendment moves target closing date from March 22 to April 22, 2026.
-
Totaligent extends target date for Aetherium Medical acqui-hire to April 10, 2026
Extension Amendment moves negotiation and closing deadline from March 5, 2026 to April 10, 2026.
-
Totaligent extends target closing date for Aetherium Medical acqui-hire to March 20, 2026
Extension Amendment moves target date for definitive agreements and closing from March 5 to March 20, 2026.
-
GloMed has ~$10M annual revenue and ~$1M free cash flow; distributes biologics/devices in APAC via 20+ KOLs.
-
Totaligent enters acqui-hire LOI with Aetherium Medical; 10% equity stake, no cash
Acquiring Aetherium's team, IP, business plan in exchange for 10% of Totaligent's outstanding common stock as restricted preferred.
-
Totaligent enters IR/PR consulting agreement; issues 5M shares as compensation
Agreement with 247MarketNews for six-month IR/PR services starting Sept 8, 2025.
-
Totaligent enters conversion limitation agreement with Karolus Maximus Kapital
Agreement limits conversion of ~20 promissory notes so investor cannot own >4.99% of outstanding common stock.
-
Brian Heckathorne elected director, Ben Hansel resigns from Totaligent board
Ben Hansel resigned as director effective April 18, 2025; departure not due to any disagreement with company.
Executive changes
Appointed
Brian Heckathorne
director
TGNT ·
Totaligent, Inc.
Effective April 18, 2025, the Board of Directors of the Company elected Brian Heckathorne to serve as a director.
Materiality & sentiment trend
Max materiality 0.75 · Median 0.30 · Most common event m_and_a